Novo Nordisk A/S

NVO · OMX

$39.05−$0.38 (−0.96%)TodayMarket closed ·
Prev close $39.43

Who owns NVO

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 20.6% of NVO’s shares.

  • Novo A/S5.2%
  • Vanguard Capital Management, LLC3.1%
  • Capital Research Global Investors2.4%
  • Norges Bank Investment Management (NBIM)2.1%
  • Next 6 largest institutions7.8%
  • All other shareholders79.4%
Top institutional holders of NVO
HolderShares% of shares
Novo A/S177.56M5.24%
Vanguard Capital Management, LLC105.57M3.11%
Capital Research Global Investors80.01M2.36%
Norges Bank Investment Management (NBIM)70.80M2.09%
BlackRock Institutional Trust Company, N.A.63.77M1.88%
Aviva Investors Global Services Limited61.16M1.80%
Capital World Investors53.71M1.58%
Geode Capital Management, L.L.C.36.16M1.07%
BlackRock Advisors (UK) Limited25.76M0.76%
DWS Investment GmbH24.89M0.73%

Largest mutual fund holders

Top mutual fund holders of NVO
HolderShares% of shares
Statens Pensjonsfond Utland70.80M2.09%
Vanguard Total International Stock Index Fund46.91M1.38%
American Funds EUPAC Fund36.20M1.07%
Vanguard Developed Markets Index Fund31.25M0.92%
American Funds Capital World Growth & Income Fund26.02M0.77%

Congressional trades

Disclosed by members of Congress over the last 12 months

NVO trades disclosed by members of Congress
MemberTypeAmountTraded
Kevin HernHouseSale$1K–$15KSep 10, 2026
Kevin HernHouseSale$1K–$15KAug 31, 2026
Clifford FranklinHousePurchase$1K–$15KAug 26, 2026
Alan ArmstrongSenatorPurchase$15K–$50KMar 30, 2026
Lisa McClainHouseSale$1K–$15KOct 31, 2025
Lisa McClainHouseSale$1K–$15KOct 30, 2025

Short interest

Settled Sep 30, 2026

Shares short
31.62M
Days to cover
1.74
% of shares outstanding
0.93%
Average daily volume
18.16M
Change since last report
+20.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.